Rheumatoid Arthritis

Editor's Choice

Rheumatoid arthritis in elderly patients

Aggressive rheumatoid arthritis treatment should not be withheld in the geriatric population just because of advanced age, but rather treatment should be individualized, especially considering comorbidities and other factors that can specifically affect a patient's quality of life. Coordination of care among geriatricians and rheumatologists is the key to achieving optimal outcome.

LATEST ARTICLES

Rheumatoid arthritis in elderly patients

Golimumab: A human anti-TNF-alpha monoclonal antibody for the treatment of autoimmune joint diseases

Golimumab is a human anti-tumor necrosis factor (TNF)-alpha monoclonal antibody that was recently approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

The child with joint pain

Review of musculoskeletal complaints in children and diagnostic approach to dealing with joint pain.

Biologic agents for the management of rheumatoid arthritis (CE)

After participating in this activity, pharmacists should be able to describe the epidemiology and pathophysiology of rheumatoid arthritis (RA); identify its clinical presentation and diagnostic criteria; explain current pharmacologic treatment strategies; discuss the role of the newer, biologic agents; and provide appropriate recommendations for a designated patient.

Best Practices in the Diagnosis and Management of Rheumatoid Arthritis (CME)

Current, accurate, and relevant information on the pathogenesis of rheumatoid arthritis, as well as practical guidance in symptom control and overall disease management with the goal of improving quality of life for patients with the disease.